News | Neuro Imaging | August 31, 2015

Researchers Track Brain Activity of Psychotics During Movie Viewing

Results reveal difference between psychotics and control group through activity in region associated with information processing

psychotic patients, brain activity, movie viewing, fMRI, Alice in Wonderland, ECNP

August 31, 2015 — Researchers using functional magnetic resonance imaging (fMRI) have found that even first-episode psychotic patients process information differently from a control group. To ensure both groups experienced the same brain stimuli, the measurements were taken while the subjects watched a movie, Tim Burton's Alice in Wonderland. The work is being presented at the 28th European College of Neuropsychopharmacology (ECNP) conference in Amsterdam.

High-precision fMRI is often used in neuroscience to locate brain activity in response to stimuli. With psychotic patients, these experiments often look at chronically ill patients, and so the differences in brain activity shown in the scans would be more obvious than in most of real life. However, early psychosis is more difficult to detect: the patterns in the brain are not as 'hard wired' so the differences are more subtle when compared to control groups.

Given the subtle differences, researchers are also faced with the problem of trying to ensure the patients and controls receive the same stimuli while undergoing measurement, so that the brains of the patients and the controls are concentrating on the same things while being scanned. Ideally, these stimuli should be involving and information-rich, like in a real-life situation.

Now a group of Finnish researchers have come up with a creative solution: Patients and controls were scanned while watching the movie Alice in Wonderland, which guaranteed that they were receiving the same information-rich stimulus.

Using a 3-Tesla MRI device, they scanned the brains of 46 first-episode psychotic patients (meaning that they had only had one psychotic event) and 32 healthy controls, while watching the movie. The researchers found that significant differences could be seen in the precuneus region of the brain, which is an area associated with memory, visuospatial awareness, self-awareness and aspects of consciousness.

Lead researcher Eva Rikandi said: 'In this work, we attempted to determine whether a person is a first-episode psychosis patient or a healthy control subject just by looking at their brain activity recorded during movie viewing. We found, that by monitoring activity in a region known as the precuneus, we were able to distinguish patients from control subjects especially well. This would mean that the precuneus, a central hub for the integration of self- and episodic-memory-related information, plays an important role in this kind of information processing of psychotic patients.”

She continued: “We were able to achieve almost 80 percent classification accuracy using these methods. This is the first study which directly associates the beginnings of psychosis with the precuneus, so it is now important that much more research is done in this area'. The researchers hope that this approach can feed into earlier screening and better diagnosis of at-risk populations.”

ECNP President-Elect Prof. Celso Arango (Madrid) said, "The interesting question here is how patients with psychosis, even in their first episode, process information in a different way. Specifically how a movie such as Alice in Wonderland elicits the participation of different brain areas, and how that relates to the history of the person watching. What we would like to know is if patients with psychosis might see this as more or less relevant to their own life than would healthy controls. This movie is about a fantasy world, would it be different with other types of movie?"

For more information: www.ecnp-congress.eu

Related Content

FDA Clears Siemens Healthineers' GOKnee3D MRI Application
Technology | Magnetic Resonance Imaging (MRI) | February 19, 2018
The U.S. Food and Drug Administration (FDA) has cleared GOKnee3D, a magnetic resonance imaging (MRI) application from...
A brain MRI. Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns.
Feature | Magnetic Resonance Imaging (MRI) | February 16, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Arterys Receives First FDA Clearance for Oncology Imaging Suite With Deep Learning
Technology | Artificial Intelligence | February 15, 2018
Arterys Inc. announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Arterys...
AHRA and Canon Medical Systems Announce 2017 Putting Patients First Grant Winners
News | Patient Engagement | February 14, 2018
The Association for Medical Imaging Management (AHRA) and Canon Medical Systems recently announced the tenth annual...
Videos | Pediatric Imaging | February 14, 2018
ITN Associate Editor Jeff Zagoudis demonstrates several mobile apps designed to help pediatric patients learn what an
Patients Lack Information About Imaging Exams
News | Patient Engagement | February 14, 2018
Patients and their caregivers desire information about upcoming imaging examinations, but many are not getting it,...
Vantage Galan 3T XGO Edition MRI system was cleared by the FDA.
Technology | Magnetic Resonance Imaging (MRI) | February 12, 2018
February 12, 2018 — Physicians now have access to more neuro and cardiac...
PSMA PET-CT Clearly Differentiates Prostate Cancer from Benign Tissue

68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.

News | PET-CT | February 05, 2018
February 5, 2018 — Using nuclear medicine...
Overlay Init